![Vedanta Biosciences Closes Extended $45.5 Million Series C Financing](https://www.seventure.fr/wp-content/uploads/2019/02/4__104270789-322x211.jpg)
13 May 2019
Vedanta Biosciences Closes Extended $45.5 Million Series C Financing
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...